Medication for Opioid Use Disorder Dispensed More After Medicare Policy Change
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, May 25, 2023 -- Medicare payment and COVID-19 policy changes increased dispensing of medication treatment for opioid use disorder (OUD) among Medicare beneficiaries, according to a study published online May 19 in JAMA Network Open.
Erin A. Taylor, Ph.D., from RAND Corporation in Santa Monica, California, and colleagues assessed changes in rates of methadone dispensing for OUD following Medicare payment and COVID-19 policy changes in 2020. Analysis included methadone and buprenorphine treatments dispensed for 9.8 million Medicare Advantage beneficiaries from Jan. 1, 2019, through March 31, 2022.
The researchers identified 39,252 enrollees with at least one medication treatment for OUD dispensing claim (mean age, 58.6 years; 45.9 percent women), with a total of 195,196 methadone claims and 540,564 buprenorphine pharmacy claims. In 2019, the methadone dispensing rate for Medicare Advantage enrollees was 0 because the policy did not allow any payment until 2020. In the first quarter of 2020, claims rates per 1,000 enrollees were low initially (0.98), and increased to 4.71 in the first quarter of 2022. Increases were primarily seen among dually eligible beneficiaries and beneficiaries <65 years. In quarter 1 of 2019, national buprenorphine dispensing rates were 4.64 per 1,000 enrollees and increased to 7.45 per 1,000 enrollees in quarter 1 of 2022.
"These findings suggest that policies designed to increase access to methadone treatment appear to have increased access to medication treatment for Medicare beneficiaries with opioid use disorder, helping to meet national policy priorities," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Further Support and Information on COVID-19
Read this next
People With Opioid Use Disorder Less Likely to Receive Palliative Care
MONDAY, April 29, 2024 -- People with opioid use disorder (OUD) are less likely to receive palliative care during the last 90 days before death, according to a study published...
Midlife Deaths of Despair Increased From 1999 to 2022
THURSDAY, April 11, 2024 -- Midlife deaths from suicide, drug overdose, and alcoholic liver disease, collectively known as deaths of despair, increased from 1999 through 2022...
Femoral Nerve Block Cuts Opioid Use in ACL Reconstruction
MONDAY, April 8, 2024 -- For patients undergoing anterior cruciate ligament (ACL) reconstruction, a femoral nerve block (FNB) is associated with a lower incidence of excessive...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.